CellR4 2020; 8: e2986
DOI: 10.32113/cellr4_202012_2986

Brown adipose tissue transplantation as a promising approach for insulin-independent reversal of type 1 diabetes: animal studies and clinical perspectives

CellR4 2020; 8: e2955
DOI: 10.32113/cellr4_202010_2955

Human islet distribution during COVID-19 pandemic: the impact on diabetes research

CellR4 2020; 8: e2943
DOI: 10.32113/cellr4_202010_2943

GLP-1 receptor agonists can reverse immunosuppression-induced beta-cell dysfunction

CellR4 2020; 8: e2898
DOI: 10.32113/cellr4_20209_2898

The new antidiabetic agents: cardiovascular and renal protection in post-transplant diabetes mellitus

CellR4 2020; 8: e2879
DOI: 10.32113/cellr4_20207_2879

Favorable effects of omega-3 PUFAs on glucose control in an adolescent with type 1 diabetes using continuous glucose monitoring: a case report

CellR4 2020; 8: e2877
DOI: 10.32113/cellr4_20207_2877

Adipose tissue browning for the treatment of obesity and metabolic diseases

CellR4 2020; 8: e2875
DOI: 10.32113/cellr4_20207_2875

Strategies to optimize glucose control during exercise in subjects with type 1 diabetes

CellR4 2020; 8: e2850
DOI: 10.32113/cellr4_20205_2850

Targeting Toll-Like Receptor 4: a promising strategy to prevent type 1 diabetes occurrence or recurrence

CellR4 2019; 7: e2737
DOI: 10.32113/cellr4_20198_2737

Vitamin D and omega-3 field study on progression of type 1 diabetes

CellR4 2019; 7: e2735
DOI: 10.32113/cellr4_20198_2735

A case of a mild Wolfram Syndrome with concomitant ATP7B mutation

CellR4 2018; 6 (1): e2489

POSEIDON study: a pilot, safety and feasibility trial of high­-dose omega­3 fatty acids and high-­dose cholecalciferol supplementation in type 1 diabetes